USRE40792EExpiredUtilityPatentIndex 62
Health supplements containing phyto-oestrogens, analogues or metabolites thereof
Est. expiryMay 19, 2012(expired)· nominal 20-yr term from priority
Inventors:KELLY GRAHAM EDMUND
A23L 11/07A23L 33/11A61K 31/353A61K 31/35A23L 11/05A61K 36/48A61K 31/7048A61P 7/00A61P 35/00A61P 3/06A61P 5/00A61P 3/00A61P 1/00A61P 15/00A61P 15/12A61P 13/02A61P 13/08
62
PatentIndex Score
2
Cited by
413
References
19
Claims
Abstract
Compositions enriched with natural phyto-oestrogens or analogues thereof selected from Genistein, Daidzein, Formononetin and Biochanin A. These may be used as food additives, tablets or capsules for promoting health in cases of cancer, pre-menstrual syndrome, menopause or hypercholesterolaemia.
Claims
exact text as granted — not AI-modified1. A method for treating or reducing the predisposition to a condition selected from the group consisting of benign breast disease, or cancer of the prostate, or elevated blood cholesterol, said method comprising administering to a subject having said condition or predisposed to said condition to a therapeutically effective amount of a health supplement composition comprising an extract from soya or clover, said composition comprising any two or more phyto-estrogens phyto- oestrogens of the group Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides of any of said phyto-estrogens phyto- oestrogens .
2. A method according to claim 1 , wherein said composition is administered for treating benign breast disease.
3. The method according to claim 1 , wherein said phyto-oestrogen is phyto- oestrogens are extracted from soy.
4. The method according to claim 3 , wherein said phyto-oestrogen is phyto- oestrogens are extracted from soy hypocotyls.
5. A method according to claim 1 , wherein said phyto-oestrogen consists phyto- oestrogens consist essentially of (a) genistein and (b) daidzein component, wherein component (a) optionally contains biochanin A, and component (b) optionally contains formononetin, and the ratio of a):b) ( a ) to ( b ) is about 1:2 to 2.1.
6. The method according to claim 1 , wherein the phyto-oestrogen is said phyto- oestrogens are administered in an amount of from about 20 mg to 200 mg per day.
7. The method according to claim 1 , wherein the phyto-oestrogen is said phyto- oestrogens are administered in an amount of from about 50 mg to 150 mg per day.
8. The method according to claim 1 whereby the phyto-oestrogen is said phyto- oestrogens are administered at least daily, over a period of at least a month.
9. A method according to claim 1 , wherein said composition is administered for treating or reducing the predisposition to elevated levels of cholesterol in the blood stream.
10. A method according to claim 1 , wherein said composition is administered for treating cancer of the prostate.
11. A pharmaceutical preparation, in solid dosage unit form, the having a biologically active component of said preparation comprising phyto- oestrogens consisting essentially of any two or more concentrated, phytoestrogen-derived isoflavones selected from the group consisting of Genistein, Daidzein, Biochanin A, Formononetin ( a ) genistein component and ( b ) daidzein component, wherein component ( a ) optionally contains biochanin A, and component ( b ) optionally contains formononetin, or the natural glycosides of any of said phytoestrogens and phyto- oestrogens, and wherein the ratio of ( a ) to ( b ) is about 1 : 2 to 2 : 1 , said preparation including a pharmaceutically acceptable carrier.
12. A pharmaceutical preparation, as claimed in claim 11 , wherein said solid dosage unit is selected from the group consisting of a pill, tablet, coated tablet, capsule or powder.
13. A pharmaceutical preparation, as claimed in claim 12 , wherein said isoflavone is phyto- oestrogens are present in said solid dosage unit in an amount from about 20 mg. to about 200 mg. per dosage unit.
14. The pharmaceutical preparation according to claim 11 , wherein said phyto- oestrogens are extracted from soy.
15. The pharmaceutical preparation according to claim 14 , wherein said phyto- oestrogens are extracted from soy hypocotyls.
16. A method for treating or reducing the predisposition to a condition selected from the group consisting of benign breast disease, cancer of the prostate, or elevated blood cholesterol, said method comprising administering to a subject having said condition or predisposed to said condition a therapeutically effective amount of a health supplement composition comprising an extract from soy or clover, said composition comprising phyto- oestrogens, wherein the phyto - oestrogens consist essentially of ( a ) genistein and ( b ) daidzein, wherein component ( a ) optionally contains biochanin A, and component ( b ) optionally contains formononetin, wherein the ratio of ( a ) to ( b ) is about 1 : 2 to 2 : 1 .
17. The method according to claim 16 , wherein said phyto- oestrogens are administered in an amount of from about 20 mg to 200 mg per day.
18. The method according to claim 16 , wherein said phyto- oestrogens are administered in an amount of from about 50 mg to 150 mg per day.
19. The method according to claim 16 wherein said phyto- oestrogens are administered at least daily, over a period of at least a month.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.